Two Sigma Advisers’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Two Sigma Advisers’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-243,793	Closed	-$329K	–	3017
2021 Q4	$329K	Buy	243,793 +48,500	+25%	+$115K	﹤0.01%	2112
2021 Q3	$568K	Sell	195,293 -453,200	-70%	-$1.51M	﹤0.01%	1873
2021 Q2	$2.26M	Buy	648,493 +7,300	+1%	+$25.1K	0.01%	1235
2021 Q1	$2.19M	Buy	641,193 +212,700	+50%	+$4.02M	0.01%	1222
2020 Q4	$8.23M	Buy	428,493 +255,800	+148%	+$3.95M	0.02%	641
2020 Q3	$2.32M	Buy	172,693 +147,000	+572%	+$4.16M	0.01%	1082
2020 Q2	$1.09M	Sell	25,693 -700	-3%	-$22.7K	﹤0.01%	1537
2020 Q1	$729K	Buy	26,393 +600	+2%	+$17.5K	﹤0.01%	1638
2019 Q4	$837K	Buy	25,793 +4,800	+23%	+$149K	﹤0.01%	1657
2019 Q3	$546K	Buy	+20,993	New	+$702K	﹤0.01%	1684

Other funds holding ODT

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Two Sigma Advisers's ODT Position: Q1 2022 in Review

Two Sigma Advisers sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2022, closing a stake of 243,793 shares — an estimated $329K sold.

Two Sigma Advisers first reported a position in ODT in Q3 2019 and held it in 10 quarters. The position peaked at $8.23M in Q4 2020. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.

Two Sigma Advisers reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Two Sigma Advisers sold 243,793 Odonate Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $329K.
Two Sigma Advisers first reported a position in Odonate Therapeutics, Inc. Common Stock in Q3 2019 and held it in 10 quarters.
Two Sigma Advisers's Odonate Therapeutics, Inc. Common Stock position peaked at $8.23M in Q4 2020.
8 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.